(Q34679849)

3 August 2017

title

Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder (English)

1 reference

3 August 2017

0 references

autism spectrum disorder

0 references

1 reference

Maricel Cabanlit

1

1 reference

3 August 2017

Sharifia Wills

2

1 reference

3 August 2017

Paula Goines

3

1 reference

3 August 2017

Paul Ashwood

4

1 reference

3 August 2017

Judy Van de Water

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Annals of the New York Academy of Sciences

3 August 2017

published in

1 reference

3 August 2017

volume

1107

1 reference

3 August 2017

page(s)

92-103

1 reference

Autism spectrum disorders

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Incidence of autism spectrum disorders: Changes over time and their meaning*

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Pervasive developmental disorders in preschool children: confirmation of high prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Genetic studies of autism: from the 1970s into the millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Immune abnormalities in patients with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Reduced natural killer cell activity in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

CD4+ helper T cell depression in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Lymphocyte subsets and interleukin-2 receptors in autistic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Antibodies to Myelin Basic Protein in Children with Autistic Behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Circulating autoantibodies to neuronal and glial filament proteins in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Neuropathological findings in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Diagnosing autism: analyses of data from the Autism Diagnostic Interview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Multisite, double-blind, placebo-controlled trial of porcine secretin in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Cognitive profiles and social-communicative functioning in children with autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

The Pre-Linguistic Autism Diagnostic Observation Schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Abnormal psychosocial situations and ICD-10 diagnoses in children and adolescents attending a psychiatric service.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Autoantibody repertoires to brain tissue in autism nuclear families

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Glial cell influence on the human blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Three or more routes for leukocyte migration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Maternal infections and subsequent psychosis among offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Demyelination in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Immunity and behavior: antibodies alter emotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Identifying environmental contributions to autism: provocative clues and false leads

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Maternal antibrain antibodies in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Immunological treatments for autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

Neuroglial activation and neuroinflammation in the brain of patients with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1381.010

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1381.010

1 reference

3 August 2017

1 reference